Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
Matsuo
T
T
Department of Internal Medicine, Hyogo Prefectural Awaji Hospital, Japan.
Kario
K
K
Chikahira
Y
Y
Nakao
K
K
Yamada
T
T
D000368:Aged; D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D001792:Blood Platelets / Q000276:immunology; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D010875:Pipecolic Acids / Q000627:therapeutic use*; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology
D000991:Antithrombins; D007074:Immunoglobulin G; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban